Relationship between vitamin D and osteoarthritis
- Authors: Kashevarova N.G.1, Alekseeva L.I.1,2, Taskina E.A.1, Strebkova E.A.1, Sharapova E.P.1, Savushkina N.M.1, Mikhaylov K.M.1, Glukhova S.I.1, Alekseeva O.G.1, Kudinsky D.M.1, Demin N.V.1, Samarkina E.Y.1, Lila A.M.1,2
-
Affiliations:
- Nasonova Research Institute of Rheumatology
- Russian Medical Academy of Continuous Professional Education
- Issue: Vol 97, No 5 (2025): Issues of rheumatology
- Pages: 434-442
- Section: Original articles
- URL: https://journal-vniispk.ru/0040-3660/article/view/313981
- DOI: https://doi.org/10.26442/00403660.2025.05.203228
- ID: 313981
Cite item
Full Text
Abstract
Background. Osteoarthritis (OA) is a common joint disease and one of the leading causes of disability worldwide. The role of vitamin D in the etiology and development of OA is still unclear, but it may be important for both diagnosis and timely therapy.
Aim. To evaluate the relationship of vitamin D levels with clinical and instrumental parameters in OA in a cross-sectional study.
Materials and methods. The study included 171 patients aged 40–75 with confirmed knee OA according to the American College of Rheumatology (ACR) classification, stage I–III (according to Kellgren and Lawrence). All patients signed informed consent. The mean age was 53.5±9.94 years, body mass index (BMI) was 29.8±6.4 kg/m2, and disease duration was 3 [1; 7] years. For each patient, a case record form was filled out, including anthropometric indicators, medical history, clinical examination data, an assessment of knee joint pain according to the Visual Analog Scale (VAS), WOMAC, and the patient's general health condition (PGHC). All patients underwent standard radiography, knee ultrasound examination and magnetic resonance imaging (MRI) (WORMS), densitometry of the lumbar spine and femoral neck, and laboratory tests. Statistical processing of the data was performed using the Statistica 10 software.
Results. Normal vitamin D values (≥30 ng/mL) were found in 62 (36.3%) patients, low levels (<30 ng/mL) in 109 (63.7%) patients, insufficiency (<30 ng/mL and >20 ng/mL) in 66 (38.6%) patients, and deficiency (<20 ng/mL) in 43 (25.1%). Patients were divided into three groups according to the presence or absence of vitamin D insufficiency/deficiency: Group 1 included patients with normal vitamin D levels, Group 2 included patients with insufficiency, and Group 3 included patients with vitamin D deficiency. Patients of the three groups were comparable in age and disease duration but differed significantly in body weight, BMI, and waist measurement (higher in groups with reduced vitamin D values; p<0.05). Also, these patients had significantly higher VAS pain scores, total WOMAC and its components (pain, stiffness, and dysfunction), PGHC, and worse KOOS. More patients in Groups 2 and 3 had OA of the hip and hand joints, clinically detected synovitis, flat feet, and quadriceps muscle hypotrophy. Ultrasound examination significantly more often revealed a reduction of cartilage tissue on both the anteromedial and anterolateral surfaces of the knee joint; MRI showed more often osteitis in the medial condyles of the femur and tibia (p<0.05 for all values).
Conclusion. Our study demonstrated that low blood vitamin D levels (insufficiency/deficiency) were associated with a more severe knee OA. These patients had a large body weight, BMI, higher VAS pain values, WOMAC index (overall and its components), worse KOOS, PGHC, and smaller cartilage sizes in the medial parts of the knee joint (according to ultrasound); such patients were significantly more likely to have osteitis in the medial parts of the femur and tibia according to MRI. Also, stage II and III knee OA and OA of other localizations, clinically detected synovitis, quadriceps hypotrophy, and flat feet were more common.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Natalia G. Kashevarova
Nasonova Research Institute of Rheumatology
Author for correspondence.
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8732-2720
канд. мед. наук, науч. сотр. лаборатории остеоартрита
Russian Federation, MoscowLiudmila I. Alekseeva
Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-7017-0898
д-р мед. наук, зав. лаборатории остеоартрита
Russian Federation, Moscow; MoscowElena A. Taskina
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8218-3223
канд. мед. наук, ст. науч. сотр. лаборатории остеоартрита
Russian Federation, MoscowEkaterina A. Strebkova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8130-5081
канд. мед. наук, ст. науч. сотр. лаборатории остеоартрита
Russian Federation, MoscowEvgenia P. Sharapova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-4242-8278
канд. мед. наук, науч. сотр. отд. лаборатории остеоартрита
Russian Federation, MoscowNatalya M. Savushkina
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8562-6077
канд. мед. наук, науч. сотр. лаборатории остеоартрита
Russian Federation, MoscowKirill M. Mikhaylov
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0009-0000-1481-7749
врач-ревматолог
Russian Federation, MoscowSvetlana I. Glukhova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-4285-0869
канд. физ.-мат. наук, ст. науч. сотр. лаб. эволюции ревматоидных артритов
Russian Federation, MoscowOlga G. Alekseeva
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-1852-1798
канд. мед. наук, науч. сотр. лаб. инструментальной диагностики
Russian Federation, MoscowDanil M. Kudinsky
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-1084-3920
канд. мед. наук, врач-рентгенолог отд-ния лучевой диагностики
Russian Federation, MoscowNikolay V. Demin
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-0961-9785
мл. науч. сотр. лаб. остеопороза
Russian Federation, MoscowElena Yu. Samarkina
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-7501-9185
мл. науч. сотр. лаб. иммунологии и молекулярной биологии ревматических заболеваний
Russian Federation, MoscowAleksander M. Lila
Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuous Professional Education
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-6068-3080
чл.-кор. РАН, д-р мед. наук, проф., дир.
Russian Federation, Moscow; MoscowReferences
- Geng R, Li J, Yu C, et al. Knee osteoarthritis: Current status and research progress in treatment (Review). Exp Ther Med. 2023;26(4):481. doi: 10.3892/etm.2023.12180
- Yao Q, Wu X, Tao C, at al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther. 2023;8:56. doi: 10.1038/s41392-023-01330-w
- Arthritis Foundation Osteoarthritis Symptoms. Available at: https://www.arthritis.org/about-arthritis/types/osteoarthritis/symptoms.php. Accessed: 02.01.2019.
- Constantino de Campos G, Mundi R, Whittington C, at al. Osteoarthritis, mobility-related comorbidities and mortality: an overview of meta-analyses. Ther Adv Musculoskelet Dis. 2020;12:1759720x20981219. doi: 10.1177/1759720X20981219
- Mabey T, Honsawek S. Role of Vitamin D in osteoarthritis: molecular, cellular, and clinical perspectives. Int J Endocrinol. 2015:383918. doi: 10.1155/2015/383918
- Perry TA, Parkes MJ, Hodgson R, et al. Efect of Vitamin D supplementation on synovial tissue volume and subchondral bone marrow lesion volume in symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2019;20(1):76. doi: 10.1186/s12891-019-2424-4
- Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5:2502-21. doi: 10.3390/nu5072502
- Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59:881-6. doi: 10.2310/JIM.0b013e31821b8755
- Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020;12(7):2097. doi: 10.3390/nu12072097
- National Institutes of Health, Office of Dietary Supplements, “Vitamin D – Fact Sheet for Consumers,” 2021. Available at: https://ods.od.nih.gov/factsheets/Vitamind-Consumer/ Accessed: 01.02.2025.
- Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г., и др. Проект Федеральных клинических рекомендаций по диагностике, лечению и профилактике дефицита витамина Д. Остеопороз и остеопатии. 2021;24(4):4-26 [Dedov II, Melnichenko GA, Mokrysheva NG, et al. Draft federal clinical practice guidelines for the diagnosis, treatment, and prevention of vitamin D deficiency. Osteoporosis and Bone Diseases. 2021;24(4):4-26 (in Russian)]. doi: 10.14341/osteo12937
- Суплотова Л.А., Авдеева В.А., Пигарова Е.А., и др. Дефицит витамина D в России: первые результаты регистрового неинтервенционного исследования частоты дефицита и недостаточности витамина D в различных географических регионах страны. Проблемы эндокринологии. 2021;67(2):84-92 [Avdeeva VA, Suplotova LA, Pigarova EA, et al. Vitamin D deficiency in Russia: the first results of a registered, non-interventional study of the frequency of vitamin D deficiency and insufficiency in various geographic regions of the country. Problems of Endocrinology. 2021;67(2):84-92 (in Russian)]. doi: 10.14341/probl12736
- Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-44. doi: 10.3945/ajcn.115.120873
- McChesney C, Singer A, Duquette D, et al. Do not routinely test for vitamin D. BMJ. 2022;378:e070270. doi: 10.1136/bmj-2022-070270
- Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-47. doi: 10.1210/clinem/dgae290
- Heidari B, Shokri Shirvani J, Firouzjahi A, et al. Association between nonspecific skeletal pain and vitamin D deficiency. Int J Rheumatol. 2010;13:340-6. doi: 10.1111/j.1756-185X.2010.01561.x
- Pérez-López FR. Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas. 2007;58:117-37. doi: 10.1016/j.maturitas.2007.05.002
- Chaganti RK, Parimi N, Cawthon P, et al. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study. Arthritis Rheum. 2010;62:511-4. doi: 10.1002/art.27241
- Goula T, Kouskoukis A, Drosos G, et al. Vitamin D status in patients with knee or hip osteoarthritis in a Mediterranean country. J Orthop Traumatol. 2015;16:35-9. doi: 10.1007/s10195-014-0322-y
- Bischoff-Ferrari HA, Zhang Y, Kiel DP, Felson DT. Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis. Arthritis Rheum. 2005;53:821-6. doi: 10.1002/art.21601
- Mäkinen TJ, Alm JJ, Laine H, et al. The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007;40:1041-7. doi: 10.1016/j.bone.2006.11.013
- Bergink AP, Uitterlinden AG, Leeuwen JP, et al. Vitamin D status, bone mineral density, and the development of radiographic osteoarthritis of the knee: the Rotterdam Study. J Clin Rheumatol. 2009;15:230-7. doi: 10.1097/RHU.0b013e3181b08f20
- Ding C, Cicuttini F, Parameswaran V, et al. Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian older adult cohort study. Arthritis Rheum. 2009;60:1381-9. doi: 10.1002/art.24486
- Anari H, Enteshari-Moghaddam A, Abdolzadeh Y. Association between serum Vitamin D deficiency and Knee Osteoarthritis Mediterr J Rheumatol. 2019;30(4):216-9. doi: 10.31138/mjr.30.4.216
- Felson DT, Niu J, Clancy M, et al. Low serum levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum. 2007;56:129-36. doi: 10.1002/art.22292
- Sanghi D, Mishra A, Sharma AC. Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res. 2013;471:3556-62. doi: 10.1007/s11999-013-3201-6
- Gao XR, Chen YS, Deng W. The effect of vitamin D supplementation on knee osteoarthritis: A meta-analysis of randomized controlled trials. Int J Surg. 2017;46:14-20. doi: 10.1016/j.ijsu.2017.08.010
- Beaudart C, Lengele L, Leclercq V, et al. Symptomatic efficacy of pharmacological treatments for knee osteoarthritis: a systematic review and a network meta-analysis with a 6-month time horizon. Drugs. 2020;80:1947-59. doi: 10.1007/s40265-020-01423-8
- Mathieu S, Soubrier M, Peirs C, et al. A meta-analysis of the impact of nutritional supplementation on osteoarthritis symptoms. Nutrients. 2022;14:1607. doi: 10.3390/nu14081607
- Zhao ZX, He Y, Peng LH, et al. Does vitamin D improve symptomatic and structural outcomes in knee osteoarthritis? A systematic review and meta-analysis. Aging Clin Exp Res. 2021;33:2393-403. doi: 10.1007/s40520-020-01778-8
- McAlindon T, LaValley M, Schneider E. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis a randomized controlled trial. JAMA. 2013;309(2):155-62. doi: 10.1001/jama.2012.164487
- Jin X, Jones G, Cicuttini F, et al. Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients with Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2016;315:1005-13. doi: 10.1001/jama.2016.1961
- Буралкина Н.А., Арутюнова Е.Э., Власова Г.А. Глобальные проблемы витамин-D-статуса: причины, патогенетические механизмы, лечение, меры профилактики. Медицинский Совет. 2018;12:152-8 [Buralkina N A, Arutyunova EE, Vlasova GA. Global vitamin D status problems: causes, pathogenetic mechanisms, treatment, prevention measures. Medical Council. 2018;12:152-8 (in Russian)]. doi: 10.21518/2079-701X-2018-12-152-158
- Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: Global perspective. Ann Epi. 2009;19:468-83. doi: 10.1016/j.annepidem.2009.03.021
- Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88:558-642. doi: 10.1093/ajcn/88.2.558s
- Samuels J, Krasnokutsky S, Abramson SB. Osteoarthritis: a tale of three tissues. Bull NYU Hosp Jt Dis. 2008;66:244e50.
- Kwan Tat S, Lajeunesse D, Pelletier JP, Martel-Pelletier J. Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol. 2010;24:51-70. doi: 10.1016/j.berh.2009.08.004
- Dean DD, Schwartz Z, Schmitz J, et al. Vitamin D regulation of metalloproteinase activity in matrix vesicles. Connect Tissue Res. 1996;35:331-6. doi: 10.3109/03008209609029208
- Пигарова Е.А., Дзеранова Л.К., Яценко Д.А. Витамин D – вопросы всасывания и метаболизма в норме и при заболеваниях желудочно-кишечного тракта. Ожирение и метаболизм. 2022;19(1):123-33 [Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and Metabolism. 2022;19(1):123-33 (in Russian)]. doi: 10.14341/omet12835
- Hyppönen E, Boucher BJ. Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities. Nutr Rev. 2018;76:678-92. doi: 10.1093/nutrit/nuy034
- Marquina C, Mousa A, Scragg R, De Courten B. Vitamin D and cardiometabolic disorders: A review of current evidence, genetic determinants and pathomechanisms. Obes Rev. 2018;20:262-77. doi: 10.1111/obr.12793
- Pramono A, Jocken JWE, Goossens GH, Blaak EE. Vitamin D release across abdominal adipose tissue in lean and obese men: The effect of ß-adrenergic stimulation. Physiol. Rep. 2019;7:e14308. doi: 10.14814/phy2.14308
- Liang Z, Wang Z, Liu X, He Y. Confronting the global obesity epidemic: investigating the role and underlying mechanisms of vitamin D in metabolic syndrome management. Front Nutr. 2024;11:1416344. doi: 10.3389/fnut.2024.1416344
- Segal NA, Glass NA, Torner J, et al. Quadriceps weakness predicts risk for knee joint space narrowing in women in the MOST cohort. Osteoarthritis Cartilage. 2010;18(6):769-75. doi: 10.1016/j.joca.2010.02.002
- Barker T, Henriksen VT, Rogers VE, et al. Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis. Redox Biol. 2014;2(1):466-74. doi: 10.1016/j.redox.2014.01.024
- Glover TL, Goodin BR, King CD, et al. A Cross-sectional Examination of Vitamin D, Obesity, and Measures of Pain and Function in Middle-aged and Older Adults With Knee Osteoarthritis. Clin J Pain. 2015;31:1060-7. doi: 10.1097/AJP.0000000000000210
Supplementary files
